Search
Delcasertib
go.drugbank.com/drugs/DB05560InvestigationalCategories: Protein Kinase C-delta, antagonists & inhibitorsPBT-1033
go.drugbank.com/drugs/DB05565ExperimentalSynonyms: 5,7-dichloro-2-(dimethylaminomethyl)quinolin-8-ol, 8-quinolinol, 5,7-dichloro-2-((dimethylamino)methyl)-Motesanib
go.drugbank.com/drugs/DB05575InvestigationalCategories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-RingCirazoline
go.drugbank.com/drugs/DB09202ExperimentalCirazoline acts on a number of α adrenergic receptors. It is an agonist of α1A, partial agonist of α1B and α1D, and a nonselective antagonist of α2. … Cirazoline has also been shown to decrease food intake in rats, purportedly through activation of α1-adrenoceptors in the paraventricular nucleus in the hypothalamus of the brain.
Categories: Heterocyclic Compounds, 1-Ring, Adrenergic alpha-1 Receptor AgonistsSwertia japonica whole flowering
go.drugbank.com/drugs/DB14268InvestigationalSwertia japonica whole flowering is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Ginkgo biloba leaf oil
go.drugbank.com/drugs/DB14285InvestigationalGinkgo biloba leaf oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Panax ginseng root oil
go.drugbank.com/drugs/DB14286InvestigationalPanax ginseng root oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Products: Ato-KDelapril
go.drugbank.com/drugs/DB13312InvestigationalCategories: Agents Acting on the Renin-Angiotensin SystemRO7296682
go.drugbank.com/drugs/DB17531InvestigationalRO7296682 is under investigation in clinical trial NCT04642365 (A Study to Evaluate the Safety and Tolerability of RO7296682 in Combination With Atezolizumab in Participants With Advanced Solid Tumors. … RO7296682 is a monoclonal antibody against CD25 (IL-2R alpha) expressed on tumour-infiltrating regulatory T (T<sub>reg</sub>) cells.
Luveltamab tazevibulin
go.drugbank.com/drugs/DB17563Investigational[A257414] It is under investigation in clinical trial NCT05200364 (A Study of STRO-002, an Anti-folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer … Luveltamab tazevibulin, formerly known as STRO-002, is novel homogeneous folate receptor alpha (FolRα) targeting antibody-drug conjugate.